Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

NCT00045292

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States

UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States

Baylor University Medical Center Dallas, Texas, United States

View Trial Details

Completed

Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00112567

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients

NCT00082654

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

NCT00248430

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00062140

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +51 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

NCT00107354

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00002788

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

NCT00186238

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

NCT00357084

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma

NCT00636311

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions